Test Engineer - 2nd Shift

Job Description Summary

The 2nd Shift Test Engineer will work at the Houston Service Center to test Aero-derivative gas turbine engines. This role will help support testing of engines, provide technical support to test technicians, operations leadership, and to customers.

Basic Qualifications/Requirements

Desired Characteristics

About Us:

Aero Alliance is a Joint Venture that serves three segments of customers – its two parent companies, Baker Hughes and GE Vernova, as well as the Authorized Service Providers (ASP) network. At Aero Alliance, our purpose is to deliver improved product, repair & execution strategy & fulfillment with best-in-class quality, speed and cost for the JV Partners & ASPs.

Our people are the trusted experts, relied on to solve challenges big and small. We invest in the health and well-being of our workforce, train and reward talent, and develop leaders at all levels to bring out the best in each other.

We believe in creating an environment of diversity and inclusion, without bias. We know we are better when all of our people are developed, engaged, and able to bring their whole authentic selves to work. We are an Equal Opportunity Employer. Employment decisions are made without regard to race, color, religion, national or ethnic origin, gender (including pregnancy), sexual orientation, gender identity or expression, age, disability, veteran status or any other characteristics protected by law.

GE Vernova offers a great work environment, professional development, challenging careers, and competitive compensation. GE Vernova is an Equal Opportunity Employer. Employment decisions are made without regard to race, color, religion, national or ethnic origin, sex, sexual orientation, gender identity or expression, age, disability, protected veteran status or other characteristics protected by law.

GE Vernova will only employ those who are legally authorized to work in the United States for this opening. Any offer of employment is conditioned upon the successful completion of a drug screen (as applicable).

No